Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.contractpharma.com/contents/view_breaking-news/2024-04-01/fda-grants-fast-track-designation-to-lb-p8-for-treatment-of-psc/?widget=listSection
https://www.prnewswire.com/news-releases/liscure-biosciences-receives-us-fda-fast-track-designation-for-lb-p8-for-the-treatment-of-primary-sclerosing-cholangitis-psc-302102626.html
https://www.prnewswire.com/news-releases/liscure-biosciences-announces-fda-clearance-of-ind-application-to-initiate-a-phase-2-study-of-lb-p8-for-primary-sclerosing-cholangitis-psc-302074077.html
https://www.prnewswire.com/news-releases/celltrion-and-liscure-biosciences-announce-strategic-collaboration-to-develop-novel-microbiome-treatment-for-parkinsons-disease-301750379.html
https://www.prnewswire.com/news-releases/liscures-phase-2-drug-candidate-granted-orphan-drug-designation-odd-from-us-fda-301697735.html
https://www.prnewswire.com/news-releases/liscure-biosciences-announces-oral-presentation-of-new-drug-candidate-for-nash-at-upcoming-aasld-the-liver-meeting-2022-301660758.html
https://www.prnewswire.com/news-releases/abbott-and-lisc-team-up-to-address-diversity-and-equity-gaps-in-the-healthcare-industry-supply-chain-301513452.html
https://www.prnewswire.com/news-releases/liscure-biosciences-announces-research-collaboration-with-mayo-clinic-for-rare-liver-diseases-301455158.html
https://www.prnewswire.com/news-releases/liscure-biosciences-received-clinical-approval-for-two-microbiome-programs-targeting-autoimmune-disease-and-nash-301388667.html